Cittadine Andrew

CIK 00018636241 companyWILMETTE, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001863624

Recent Transactions

50 trades

Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2025-12-31+4,326→ 52,615 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Unit
2025-12-31−4,326→ 48,267 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2025-12-31$65.30/sh−1,889→ 50,726 total
Award
Monopar Therapeutics$MNPR
Stock Options
2025-12-02+8,969→ 8,969 total
Award
Monopar Therapeutics$MNPR
Restricted Stock Units
2025-12-02+13,919→ 52,593 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2025-09-30−4,327→ 38,674 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2025-09-30+4,327→ 50,185 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2025-09-30$81.67/sh−1,896→ 48,289 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2025-06-30+6,863→ 48,848 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2025-06-30−6,863→ 43,001 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2025-06-30$35.78/sh−2,990→ 45,858 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2025-03-31$36.41/sh−744→ 41,985 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2025-03-31+1,791→ 42,729 total
Award
Monopar Therapeutics$MNPR
Stock Options
2025-03-04+43,445→ 43,445 total
Award
Monopar Therapeutics$MNPR
Restricted Stock Units
2025-03-04+40,581→ 51,655 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-12-31$22.00/sh−721→ 40,938 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-12-31−1,790→ 11,074 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-12-31+1,790→ 41,659 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-09-30−1,791→ 12,864 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-09-30$6.74/sh−535→ 39,869 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-09-30+1,791→ 40,404 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-06-30−8,952→ 73,271 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-06-30$0.73/sh−2,019→ 193,065 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-06-30+8,952→ 195,084 total
Purchase
Monopar Therapeutics$MNPR
Common Stock
2024-06-20$0.74/sh+20,508→ 186,132 total
Purchase
Monopar Therapeutics$MNPR
Common Stock
2024-06-18$0.86/sh+12,000→ 165,624 total
Purchase
Monopar Therapeutics$MNPR
Common Stock
2024-06-17$0.90/sh+12,000→ 153,624 total
Purchase
Monopar Therapeutics$MNPR
Common Stock
2024-06-14$0.93/sh+12,000→ 141,624 total
Purchase
Monopar Therapeutics$MNPR
Common Stock
2024-06-13$0.91/sh+12,000→ 129,624 total
Purchase
Monopar Therapeutics$MNPR
Common Stock
2024-06-04$0.78/sh+12,000→ 117,624 total
Purchase
Monopar Therapeutics$MNPR
Common Stock
2024-06-03$0.76/sh+12,000→ 105,624 total
Purchase
Monopar Therapeutics$MNPR
Common Stock
2024-05-31$0.64/sh+12,000→ 93,624 total
Purchase
Monopar Therapeutics$MNPR
Common Stock
2024-05-30$0.64/sh+12,000→ 81,624 total
Purchase
Monopar Therapeutics$MNPR
Common Stock
2024-05-29$0.64/sh+12,000→ 69,624 total
Award
Monopar Therapeutics$MNPR
Stock Options
2024-05-22+25,000→ 25,000 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2024-03-31$0.68/sh−3,098→ 57,624 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2024-03-31+8,952→ 60,722 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-03-31−1,791→ 49,864 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2024-03-31−8,952→ 82,223 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-12-31+8,952→ 54,868 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-12-31−8,952→ 91,175 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-12-31$0.34/sh−3,098→ 51,770 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-09-30$0.62/sh−2,624→ 45,916 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-09-30+8,953→ 48,540 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-09-30−8,953→ 100,127 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-06-30−13,841→ 109,080 total
Tax Payment
Monopar Therapeutics$MNPR
Common Stock
2023-06-30$0.85/sh−4,057→ 39,587 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-06-30+13,841→ 43,644 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Common Stock
2023-03-31+4,063→ 30,957 total
Exercise/Conversion
Monopar Therapeutics$MNPR
Restricted Stock Units
2023-03-31−4,063→ 44,687 total

Companies

Monopar Therapeutics
Chief Operating Officer
$MNPR

Recent Filings

Address

1000 SKOKIE BLVD SUITE 350

WILMETTE, IL, 60091

View on SEC.gov